SEARCH

SEARCH BY CITATION

References

  • 1
    Bruun E. Control examination of the specificity of specific desensitization in asthma. Acta Allergol 1949;2: 122.
  • 2
    Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. New Engl J Med 1978;299: 157161.
  • 3
    Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users’ guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 1995;274: 18001804.
  • 4
    Malling H-J, Weeke B. EAACI immunotherapy position papers. Allergy 1993;48(Suppl. 14):935.
  • 5
    BousquetJ, LockeyRF, MallingH-J (eds). WHO Position Paper. Allergen Immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53(Suppl. 44):142.
  • 6
    Bousquet J, Van Cauvenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108: 147334.
  • 7
    Wilson DR, Torres Lima M, Durham SE. Sublingual immunotherapy for allergic rhinitis. The Cochrane Database Syst Rev 2003;2: CD002893.
  • 8
    Canonica GW, Passalacqua G. Noninjective routes for immunotherapy. J Allergy Clin Immunol 2003;111: 437448.
  • 9
    Malling H-J. Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2002;2: 523531.
  • 10
    Tonnel AB, Scherpereel A, Douay B, Mellin B, Leprince D, Goldstein N et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004;59: 491497.
  • 11
    Sheikh A, Hurwitz B. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2001;4: CD001563.
  • 12
    Frew AJ, White PJ, Smith HE. Sublingual immunotherapy. J Allergy Clin Immunol 1999;104: 267270.
  • 13
    Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001;134: 657662.
  • 14
    Altman DG, Bland JM. How to randomise. BMJ 1999;319: 703704.
  • 15
    Enas GG, Enas NH, Spradlin CT, Wilson MG, Wiltse CG. Baseline comparability in clinical trials. Drug Inf J 1990;24: 541548.
  • 16
    Treasure T, MacRae KD. Minimisation: the platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does. BMJ 1998;317: 362363.
  • 17
    Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Guyatt GH. In the dark: physician interpretations and expert definitions of blinding in randomized controlled trials. JAMA 2001;285: 20002003.
  • 18
    Malling H-J. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53: 461472.
  • 19
    Campbell MJ, Julious SA, Altmann DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995;311: 11451148.